Connect with us

Technology

Lichen China Limited Announces $3.4 Million Registered Direct Offering

Published

on

XIAMEN, China, Jan. 28, 2025 /PRNewswire/ — Lichen China Limited (Nasdaq: LICN) (“Lichen China” or the “Company”), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 42,500,000 of the Company’s Class A ordinary share, par value $0.00004 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.08 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share.

The aggregate gross proceeds to the Company of this offering are expected to be approximately $3.4 million. The transaction is expected to close on or about January 29, 2025, subject to the satisfaction of customary closing conditions.

Univest Securities, LLC is acting as the sole placement agent.

The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-277230) previously filed by the Company and declared effective by the U.S. Securities and Exchange Commission (“SEC”) on March 1, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC’s website at www.sec.gov.

About Lichen China Limited

Lichen China Limited focuses on providing financial and taxation solution services, education support services, and software and maintenance services under its “Lichen” brand. In recognition of the Company’s expertise and experience in the financial and taxation solution services industry for over 18 years, the Company has built up its reputation as a dedicated financial and taxation solution services provider of professional and high-quality services in China. For more information, please visit the Company’s website: https://ir.lichenzx.com/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.

For more information, please contact:

Tian Sun
Phone: +86-0592-5586999
Email: ir@lichenzx.com

View original content:https://www.prnewswire.com/news-releases/lichen-china-limited-announces-3-4-million-registered-direct-offering-302362363.html

SOURCE Lichen China Limited

Continue Reading

Technology

Epson to Showcase Collaborative 6-Axis Robot and Integrated Automation Solutions at The ASSEMBLY Show 2026

Published

on

By

AX6 Cobot and Live Demonstrations Highlight Epson’s Expanding Automation Portfolio

LOS ALAMITOS, Calif., Oct. 21, 2026 /PRNewswire/ — Epson Robots, the #1 SCARA robot manufacturer in the world, will showcase its expanding automation portfolio, including its first collaborative robot, the AX6, at The ASSEMBLY Show 2026, taking place in Rosemont, Illinois from Oct. 27-29, 2026, in booth #331.

Epson to Showcase AX6 Cobot and Integrated Automation Solutions with Live Demos at The ASSEMBLY Show 2026

“Every automation application has different safety requirements, and there is no one-size-fits-all approach,” said Scott Marsic, group product manager, Epson Robots. “With the AX6 and SafeSenseTM technology, Epson is giving manufacturers more options to select the right solution for their requirements. At The ASSEMBLY Show, we look forward to demonstrating how these offerings complement our broader robotics portfolio and help manufacturers address a wide range of automation needs.”

With Epson’s latest automation technologies, attendees can experience live demonstrations showcasing integrated robotics, vision, and feeding solutions. The live applications will highlight practical, cost-effective solutions for real-world production environments. An educational speaking session will also focus on selecting the right automation approach for each application. Epson highlights at The ASSEMBLY Show 2026 will include:

Speaking Engagement”Automation Isn’t the Answer. Choosing the Right Automation Is.” – Marsic will outline a practical framework for choosing the right automation strategy, from evaluating opportunities and avoiding application creep to balancing critical design considerations such as safety, robot geometry, workcell design and flexibility. The session will focus on solving the right business problem to create automation systems that are easier to implement, scale and maintain while delivering stronger productivity, reliability and long-term ROI. The session will take place Wednesday, October 28 from 2 – 2:30 p.m. at the Learning Theater.AX6 Collaborative 6-Axis Robot – See Epson’s first collaborative robot in action, featuring a lightweight, compact footprint and intuitive no-code software designed to simplify programming and deployment. Power- and force-limiting capabilities and flexible end-of-arm options support collaborative applications where space, ease of use and fast redeployment are priorities.SafeSense Interactive Demo – Experience a hands-on demonstration of Epson’s SafeSense technology, which uses sensors to detect when a person enters the robot’s workspace, supporting safe human-robot interaction while maintaining high-performance automation.IntelliFlexTM Feeding System – See live demonstrations featuring Epson’s latest SCARA and 6-Axis robots integrated with IntelliFlex Feeding Systems for automated part handling and assembly applications.Epson RC+® Development Software – Explore Epson’s PC-based environment with intuitive GUI Builder for custom interfaces along with integrated vision and IntelliFlex capabilities. Developed and supported by Epson, the software is designed to simplify automation development and deployment.

The ASSEMBLY Show 2026 will take place on Oct. 27 from 4 p.m. to 7 p.m. CDT, Oct. 28 from 10 a.m. to 5 p.m. CDT and Oct. 29 from 9 a.m. to 2 p.m. CDT at the Donald E. Stephens Convention Center in Rosemont, Illinois. To learn more about Epson robot solutions at the show, stop by booth #331 or visit www.epsonrobots.com to contact a robot expert.

About Epson Robots

Epson Robots is a global leader in PC-controlled precision factory automation, with well over 250,000 units sold worldwide1 and a product line of hundreds of models of easy-to-use SCARA and 6-Axis robots based on a common PC-based platform. Building on four decades of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For more information, visit www.epsonrobots.com.

About Epson

Epson is a technology innovation and engineering company whose philosophy of efficient, compact and precise innovation enriches lives and helps create a better world. The company uses technology and engineering ability to implement real-world solutions in precision innovation, industrial and robotics, office and home printing, and visual and lifestyle.

Led by the Japan-based Seiko Epson Corporation, the worldwide Epson Group generates annual sales of more than JPY 1.4 trillion. corporate.epson/en/

Epson America, Inc., based in Los Alamitos, Calif., is Epson’s regional headquarters for the U.S., Canada and Latin America. To learn more about Epson, please visit: epson.com. You may also connect with Epson America on Facebook (facebook.com/Epson), X (x.com/EpsonAmerica), YouTube (youtube.com/epsonamerica) and Instagram (instagram.com/EpsonAmerica).

1 Epson internal sales data through April 2026.

EPSON and Epson RC+ are registered trademarks of Seiko Epson Corporation. SafeSense and IntelliFlex are trademarks of Epson America, Inc. All other product and brand names are trademarks and/or registered trademarks of their respective companies. Epson disclaims any and all rights in these marks. Copyright 2026 Epson America, Inc.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/epson-to-showcase-collaborative-6-axis-robot-and-integrated-automation-solutions-at-the-assembly-show-2026-302915812.html

SOURCE Epson America, Inc.

Continue Reading

Technology

Limber Health Launches Recovery Forecast, the First-Ever Predicted Outcomes Solution for Rehab Therapy

Published

on

By

Built on the largest risk-adjusted patient outcomes database in rehab therapy, Limber’s Recovery Forecast replaces traditional single point-in-time forecasts or MCID comparisons with a 90-day outlook

PITTSBURGH, Oct. 21, 2026 /PRNewswire/ — Limber Health, a Net Health company, today announced Recovery Forecast, the first-ever predicted outcomes trajectory solution for rehab therapy. Built into the Limber outcomes platform, Recovery Forecast maps each patient’s expected path throughout care by comparing them with millions of completed assessments and applying robust risk adjustment. Available to clients this fall, this new clinical capability covers the primary MSK regions of injury.

“Current solutions show a point-in-time measurement, but rarely provide context or insight into the score,” said Nirav Modi, president of Limber Health. “Recovery Forecast shows clinicians how a patient is progressing through their plan of care, so they can assess, adjust, and guide them toward the best possible improvement.”

Because Limber Outcomes follows patients from evaluation through the full episode of care, the expected path stays visible between visits. At intake, the feature predicts each patient’s path; then at each reassessment, clinicians compare the actual score with the prediction for real-time context. This gives clinicians an opportunity to adjust the course of care.

“Being able to predict a patient’s outcome trajectory is a game changer,” said Brian Kelly, Vice President of Innovation & Clinical Excellence at Ivy Health. “It transforms outcomes data into real-time clinical intelligence that enhances patient engagement, empowers proactive clinical decision-making, and ensures every patient is positioned for an optimal recovery.”

A newly developed progression indicator, the Predicted Moderate Clinical Improvement (P-MCI), marks where a patient is expected to reach clinically meaningful improvement. P-MCI is already part of commercial payer quality programs. It underpins five functional improvement measures in the CMS proposed rule for the 2027 Physician Fee Schedule, with Limber Health and Patient360 as measure stewards. For more information about Limber Recovery Forecast, click here. 

About Limber Health

Limber Health, a Net Health company, extends in-person musculoskeletal (MSK) care into the home with Remote Therapeutic Monitoring (RTM), Home Exercise Programs (HEP), and Limber Outcomes, which helps practices measure patient progress and predict recovery using the largest risk-adjusted patient outcomes database in rehab therapy. Limber’s solutions are developed by physical therapists and physicians. Learn more at www.limberhealth.com.

About Net Health

For over 30 years, Net Health has gathered specialty knowledge shaped by human expertise and informed by patient outcomes. Today, this depth of knowledge is the foundation for an AI-native specialty platform that delivers intelligence to clinicians across the care continuum, enabling them to be present with patients during the moments that matter. Net Health is a trusted source of specialty solutions for more than 34,000 healthcare organizations, and is a portfolio company of The Carlyle Group, Level Equity, and Silversmith Capital Partners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/limber-health-launches-recovery-forecast-the-first-ever-predicted-outcomes-solution-for-rehab-therapy-302915819.html

SOURCE Net Health Systems, Inc.

Continue Reading

Technology

Asuri.ai Launches Multi-Agent AI Platform for Persistent Business Workflows

Published

on

By

The agentic platform helps nontechnical teams save time, eliminate redundant work and deploy specialized AI agents across more than 1,000 existing applications

IRVINE, Calif., Oct. 21, 2026 /PRNewswire/ — Asuri today announced the launch of its multi-agent enterprise AI platform, designed to help businesses move beyond copilots and deploy persistent AI workflows across complete business processes.

As AI models become more capable, the challenge for businesses is shifting from generating answers to safely giving AI the context, system access and autonomy required to perform real work.

Asuri brings those pieces into one platform.

Nontechnical teams can define a business process, connect the applications involved, assign specialized agents to different responsibilities, and control what each agent can access, recommend or execute. By coordinating work that would otherwise require employees to repeatedly move between systems, gather information and perform routine follow-ups, Asuri helps organizations save time and remove redundant manual work.

“The model itself is becoming less of the bottleneck,” said Artem Bespaloff, CEO and co-founder of Asuri. “The harder problem is coordinating agents across real business systems while giving each one the right context, permissions and level of autonomy.”

Unlike traditional AI assistants that primarily respond to prompts, Asuri is designed around persistent multi-agent workflows.

Asuri combines multi-agent orchestration, workflow logic, persistent context and agent-level permission controls in a single environment, with more than 1,000 integrations connecting agents to the software businesses already use.

This allows companies to automate processes across existing systems instead of replacing their technology stack, reducing repetitive administrative work and freeing employees to focus on higher-value decisions and relationships.

As part of its launch, Asuri is introducing prebuilt customer intelligence workflows that consolidate information from multiple business systems, analyze client activity against company-defined rules, and automatically alert employees to significant developments. By eliminating the need to manually track client activity across different platforms, these workflows reduce the workload on sales and research teams, helping them stay informed, identify opportunities, and focus on higher-value activities.

The same architecture can support workflows across sales, operations, finance, customer success, research and internal compliance.

Businesses can learn more and request access at Asuri.ai.

About Asuri

Asuri is a multi-agent enterprise AI platform, built by Sprouter Technologies, for persistent, governed business workflows. With more than 1,000 integrations, Asuri helps organizations connect specialized AI agents across their existing applications, reduce repetitive work, save employee time and automate processes while maintaining individual permissions, autonomy boundaries and human oversight.

For more information you can contact team@asuri.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/asuriai-launches-multi-agent-ai-platform-for-persistent-business-workflows-302915829.html

SOURCE Sprouter Technologies

Continue Reading

Trending